(See also Overview of Immunodeficiency Disorders Overview of Immunodeficiency Disorders Immunodeficiency disorders are associated with or predispose patients to various complications, including infections, autoimmune disorders, and lymphomas and other cancers. Primary immunodeficiencies... read more and Approach to the Patient With an Immunodeficiency Disorder Approach to the Patient With Suspected Immunodeficiency Immunodeficiency typically manifests as recurrent infections. However, recurrent infections are more likely to have causes other than immunodeficiency (eg, inadequate treatment, resistant organisms... read more .)
IgA deficiency involves B cell defects Humoral immunity deficiencies Immunodeficiency disorders are associated with or predispose patients to various complications, including infections, autoimmune disorders, and lymphomas and other cancers. Primary immunodeficiencies... read more . Prevalence ranges from 1/100 to 1/1000.
The inheritance pattern is unknown, but having a family member with selective IgA deficiency increases the risk by about 50 times.
Some patients have mutations in the TACI (transmembrane activator and calcium-modulator and cyclophilin ligand interactor) gene. Selective IgA deficiency also commonly occurs in patients with certain HLA haplotypes; rare alleles or deletions of genes in the major histocompatibility complex Human Leukocyte Antigen (HLA) System (MHC) class III region are common.
Drugs such as phenytoin, sulfasalazine, gold, and penicillamine may lead to IgA deficiency in some patients.
Symptoms and Signs of Selective IgA Deficiency
Most patients with selective IgA deficiency are asymptomatic; others have recurrent sinopulmonary infections, diarrhea, allergies (eg, asthma, associated nasal polyps), or autoimmune disorders (eg, celiac disease, inflammatory bowel disease, systemic lupus erythematosus, chronic active hepatitis).
Anti-IgA antibodies may develop after exposure to IgA in transfusions, immune globulin (IVIG), or other blood products; rarely, if reexposed to these products, patients may have anaphylactic reactions Anaphylaxis Anaphylaxis is an acute, potentially life-threatening, IgE-mediated allergic reaction that occurs in previously sensitized people when they are reexposed to the sensitizing antigen. Symptoms... read more .
Diagnosis of Selective IgA Deficiency
Measurement of serum Ig levels
Measurement of antibody response to vaccine antigens
Diagnosis of selective IgA deficiency is suspected in patients who have recurrent infections (including giardiasis), anaphylactic transfusion reactions, or a family history of common variable immunodeficiency Common Variable Immunodeficiency (CVID) Common variable immunodeficiency (acquired or adult-onset hypogammaglobulinemia) is characterized by low immunoglobulin (Ig) levels with phenotypically normal B cells that can proliferate but... read more (CVID), IgA deficiency, or autoimmune disorders or who are taking drugs that lead to IgA deficiency.
Suspected patients should have immunoglobulin levels measured; diagnosis is confirmed by a serum IgA level < 7 mg/dL (< 70 mg/L, 0.4375 micromol/liter ) with normal IgG and IgM levels. IgG antibody titers are measured before and after administration of vaccine antigens; patients should have a normal rise in antibody titers ( ≥ 2-fold increase in titer at 2 to 3 weeks).
Testing of family members is not recommended because most patients with low IgA have no clinically significant manifestations. However, patients who have a history of transfusion-related reactions should be tested for IgA deficiency, particularly if they have a family member with IgA deficiency.
Prognosis for Selective IgA Deficiency
A few IgA-deficient patients develop CVID over time; others improve spontaneously. Prognosis is worse if an autoimmune disorder develops.
Treatment of Selective IgA Deficiency
Antibiotics as needed for treatment and, in severe cases, for prophylaxis
Avoidance of blood products that contain IgA
Allergic manifestations are treated. Antibiotics are given as needed for bacterial infections of the ears, sinuses, lungs, or gastrointestinal or genitourinary tracts. In severe cases, antibiotics are given prophylactically.
Because immune globulin replacement therapy contains mostly IgG and minimal amounts of IgA, patients with IgA deficiency do not benefit from it. However, there still is some risk of sensitizing patients to IgA or triggering an anaphylactic reaction in those who previously developed anti-IgA antibodies. Rarely, if patients have no antibody response to vaccines and if prophylactic antibiotics are ineffective in preventing infection, specially formulated immune globulin preparations that contain extremely low levels of IgA can be tried and may be somewhat effective.
Blood products that contain IgA are avoided in patients with IgA deficiency because IgA can elicit an anti-IgA–mediated anaphylactic reaction. If transfusion of red blood cells (RBCs) is needed, only washed packed RBCs can be used. If other blood components are needed, they should be IgA-deficient, and cellular components should be washed.
Patients with selective IgA deficiency are advised to wear an identification bracelet to prevent inadvertent plasma or immune globulin administration, which could lead to anaphylaxis.
Selective IgA deficiency is the most common primary immunodeficiency.
Patients may be asymptomatic or have recurrent infections or autoimmune disorders; some develop CVID over time, but in others, selective IgA deficiency spontaneously resolves.
Suspect selective IgA deficiency if patients have anaphylactic reactions to transfusions, take drugs that lead to IgA deficiency, or have recurrent infections or a suggestive family history.
Confirm the diagnosis by measuring Ig levels and antibody titers after vaccines are given; an IgA level < 7mg/dL (< 70 mg/L) and normal IgG and IgM levels and antibody titers are diagnostic.
Give antibiotics as needed and, in severe cases, prophylactically.
Avoid giving patients blood products or immune globulin that contain more than minimal amounts of IgA.
Drugs Mentioned In This Article
|Drug Name||Select Trade|
|Dilantin, Dilantin Infatabs, Dilantin-125, Phenytek|
|Azulfidine, Azulfidine En-Tabs, Sulfazine , Sulfazine EC|
|Cuprimine, Depen, D-PENAMINE|